Izvorni znanstveni članak
https://doi.org/10.3325/cmj.2019.60.397
A novel percutaneous transhepatic treatment of a benign bile duct stricture – a pilot study
Orsolya Huszár
; 1st Department of Surgery Semmelweis University, Budapest, Hungary
Attila Szijarto
; 1st Department of Surgery Semmelweis University, Budapest, Hungary
Tibor Tihanyi
; 1st Department of Surgery Semmelweis University, Budapest, Hungary
László Harsányi
; 1st Department of Surgery Semmelweis University, Budapest, Hungary
Ákos Szücs
; 1st Department of Surgery Semmelweis University, Budapest, Hungary
Sažetak
Aim To assess the effectiveness and outcome of repeated
percutaneous transhepatic balloon dilatation combined
with targeted intramucosal corticosteroid injection in patients
with benign biliary stricture.
Methods This single-center pilot study, conducted between
February 2014 and June 2016, involved five patients
with benign biliary stricture (4 men and 1 woman, mean
age 58.2 years). The study included only patients in whom
previous surgical or/and non-surgical treatments failed or
could not be performed due to patients’ medical history
and local status.Results We successfully developed an alternative treatment
for patients with benign biliary stricture and performed
it without side effects. There were no major
complications, and the only one minor complication
was cholangitis. In the median follow-up period of 30.24
months (range 14.5 to 44.6 months), no re-occlusion was
detected. The disease-free survival, calculated after excluding
the first patient (who died of heart attack), was 34.175
months.
Conclusion Percutaneous transhepatic corticosteroid injection
combined with balloon dilatation could provide
an alternative method for the treatment of benign biliary
strictures that is effective in the long term and results in
positive outcomes.
Ključne riječi
Hrčak ID:
240103
URI
Datum izdavanja:
15.10.2019.
Posjeta: 664 *